Where is Parexel located?

Parexel is headquartered in Waltham, United States. It is registered at Newton, Massachusetts.

Who is the current CEO of Parexel?

Jamie Macdonald of Parexel. They are also an angel investors in 1 startup.

How many employees does Parexel have?

As of Aug 31, 2026, the latest employee count at Parexel is 22336.

How much is Parexel worth?

The last known valuation of Parexel was $***** as of Jul 02, 2021.

What is the annual revenue of Parexel?

Annual revenue of Parexel is more than $1B as on Jun 30, 2017

Where does Parexel rank among its competitors?

Parexel ranks 5th amongst 339 active competitors, of which 14 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was ClinChoice, which secured $150M in Jul, 2022.

Who are the top competitors of Parexel?

Parexel's top competitors include Veristat, Siro Clinpharm and Emmes. Among them, ClinChoice secured the most recent funding round in July, 2022.

Parexel - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Parexel International is a clinical research organization offering various services which broadly include consulting, clinical research, access, and informatics. Clinical research services include early phase services, phase II-III services, phase IIIb-IV, quantitative clinical development, genomic medicine, clinical trial supplies, clinical development Optimization and customer care. Informatics include perceptive MyTrials (Single-Point Access to Both Data and Applications to Simplify clinical trials), study Management and monitoring, clinical data management, pulmonary function testing and medical imaging. Consulting services include integrated product development, regulatory compliance, risk management and regulatory outsourcing. Access services include late-stage clinical operations, market access consulting, drug safety services and medical Communications. They offer their services for the clinical development of pharmaceuticals, medical devices, biologics, and biosimilars. They are currently present in 51 countries.

Website: www.parexel.com/
Social
Registered Address: Newton, Massachusetts

Key Metrics

Founded Year

1983

Location

Waltham, United States

Stage

Acquired

Last Known Valuation

$***** as on Jul 02, 2021

Investors

Vedanta Capital & 3 more

Ranked

5^th among 339 active competitors

Annual Revenue

$1B+ as on Jun 30, 2017

Employee Count

22,336 as on Aug 31, 2026

Investment & Acquisitions

Vitrana & 13 more

Similar Companies

Veristat & 404 more

Exit Details

Acquired by EQT (Jul 02, 2021)

View Parexel's full profile

Parexel is associated with 10 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SRIAS LIFE SPACES LLP CIN: AAX-3008 , India, Active	Jun 07, 2021	0 - ₹10 Cr (As on Mar 31, 2025)	-
The Republic International Co. s.r.o. CIN: 08504393 , Czech Republic, Active	Sep 11, 2019	-	-
PHAMCO s.r.o. CIN: 05694001 , Czech Republic, Active	Jan 11, 2017	-	-
PAREXEL INTERNATIONAL D.O.O. CIN: 69992332029 , Croatia, Active	May 19, 2008	$1M - $10M (As on Dec 31, 2022)	-
PAREXEL INTERNATIONAL CORP CIN: 799729 , United States, Active	Oct 24, 2021	$1B+ (As on Jun 30, 2017)	-	-
HERON HEALTH PRIVATE LIMITED CIN: U85100TS2007PTC190925 , India, Active	Sep 21, 2007	₹100 - ₹500 Cr (As on Mar 31, 2025)	735 (As on Feb 29, 2024)
PAREXEL INTERNATIONAL SERVICES INDIA PRIVATE LIMITED CIN: U74900CH2014FTC035339 , India, Active	Dec 26, 2014	₹100 - ₹500 Cr (As on Mar 31, 2025)	748 (As on Aug 01, 2025)
PAREXEL INTERNATIONAL (INDIA) PRIVATE LIMITED CIN: U74999TG2006PTC051626 , India, Active	Nov 11, 2006	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	3346 (As on Apr 01, 2026)
PAREXEL INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED CIN: U74220KA2006PTC039077 , India, Active	Apr 24, 2006	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
Parexel International Corporation CIN: 42776269 , United States, Active	Dec 26, 999	-	5084 (As on Dec 31, 2024)	-

Parexel got acquired by EQT and Goldman Sachs Asset Management on Jul 02, 2021 at an acquisition amount of $*****.

Click here to take a look at Parexel's acquisition in detail

Parexel is a funded company. Parexel has 4 institutional investors.

View details of Parexel's funding rounds and investors

Parexel's employee count trend

Parexel has 22,336 employees as of Aug 26. Here is Parexel's employee count trend over the years:

Uncover Parexel's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Parexel include Veristat, Siro Clinpharm and Emmes. Here is the list of Top 10 competitors of Parexel, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, WindRose Health Investors ... & 2 others	60/100
2nd	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	60/100
3rd	Emmes 1977, India, Acquired	Provider of outsourced CRO services	-	Behrman Capital, Apollo Investment Corporation ... & 1 others	60/100
4th	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Adams Street Partners, Veritas Capital & 4 others	58/100
5th	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Vedanta Capital, Boston Capital Ventures & 2 others	57/100
6th	Celgene 1986, Summit (United States), Acquired	Developer of therapies for treating cancer and inflammatory diseases	$45M	Piper Jaffray, Gershon Capital & 12 others	57/100
7th	Premier Research 1989, Durham (United States), Public	Provider of clinical trial CRO services	-	alzheimerlondon.ca, HarbourVest Partners & 4 others	55/100
8th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	54/100
9th	ClinChoice 1995, Fort Washington (United States), Series E	CRO focused on data management, regulatory affairs and consulting services	$212M	Goldman Sachs, Legend Capital & 8 others	53/100
10th	Worldwide Clinical Trials 1986, Beverly Hills (United States), Acquired	Global CRO providing personalized support for clinical trials across diverse therapeutic areas	-	TJC, Scrip Awards	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Parexel's competitors? Click here to see the top ones

Parexel has not made any investments yet. Parexel has made 14 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 29, 2026	Acquisition	Vitrana	2014	Noida (India)
Feb 20, 2020	Acquisition	Model Answers	2005	Brisbane (Australia)
Feb 01, 2017	Acquisition	The Medical Affairs Company	2007	Kennesaw (United States)